When Will U.S. Shale Rebound To Pre-Pandemic Levels? By

New Post Public Reply Private Reply Replies (0) Message Board
SaltyMutt
272
When Will U.S. Shale Rebound To Pre-Pandemic Levels?

By Nick Cunningham - Jun 17, 2020

2020-06-17_eh7fvuazg0.jpg

The rebalancing of the oil market has been possible, in part, due to the sharp cutbacks in U.S. shale production. But what happens next for the industry?

The latest data from the EIA estimates that production plunged by a colossal 600,000 bpd in the week ending on June 12, a massive decline that puts output down more than 2.6 million barrels per day (mb/d) from the weekly peak hit in mid-March (to be sure, monthly EIA data shows the U.S. hit a slightly lower peak in November 2019).

At the same time, the industry is bringing shuttered production back online. Reuters says that 500,000 bpd of shut-in production could be restored by the end of June. For instance, Devon Energy shut in about 10,000 bpd in recent weeks, but is “in the process of bringing all of that back on,” Devon Energy CEO David Hager said at a JPMorgan conference on Tuesday, according to Reuters.

Analysts have varying perspectives on what happens next for shale drilling. According to Morgan Stanley, the industry will proceed in three phases. First, shut-in wells come back online. Then production stabilizes, but an average of $40 per barrel will be needed for that to occur. Finally, production growth resumes, assuming prices move back up to $50 per barrel.

However, there is “little room for US production to grow this year or next,” Morgan Stanley cautioned, noting that if output began to rise, it would merely derail the oil price rally. The capex cuts announced to date should translate into production declines of 1.8-1.9 million barrels per day by the end of 2020, compared to the end of 2019.

The bank said that the shale industry will need two years or so of WTI averaging at least $50 per barrel in order for shale output to rebound to pre-Covid 19 levels. “Some level of growth would likely come back quickly in the first year, and moderate thereafter without higher investment due to the reversal of temporary cost reductions, depletion of drilled-but-uncompleted (DUC) well inventory, and rising base declines,” the bank concluded.

JBC Energy forecasts WTI averaging $40 per barrel for the rest of the year. “Under this assumption we see completed wells having reached their nadir of below 200 in May with a gradual recovery to 700 by the end of the year and 1,000 by end-2021,” the firm wrote in a note.

If prices actually averaged between $45 and $50 per barrel, which would require better compliance from OPEC+ to their cuts, then it would be a “turning point” for U.S. shale, the firm argued. Shale output would reach an “inflection point” in November 2020, and see a “swift recovery thereafter,” JBC said. A year later, U.S. shale output would be back to pre-pandemic levels.

That is a more optimistic scenario. JBC’s base case calls for U.S. shale to take until September 2023 to return to peak production levels last seen earlier this year. But “[c]onsidering current sentiment…we would tend to see the risk to our shale supply base case skewed to the upside,” JBC wrote.

Others are more pessimistic, noting that both oil and broader financial markets are getting a little frothy. “ he rally across commodities has gotten ahead of fundamentals with the exception of metals,” Goldman Sachs wrote in a June 9 report.

They are not alone. “We think the oil market is not currently pricing in a significant probability of either second waves of coronavirus cases in key consumers and the associated lock-downs, or anything less than a rapid return to economic business-as-usual,” Standard Chartered wrote in a June 16 report. “We think this absence of shades of grey represents a downside risk to prices medium-term, but short-term, unnuanced hope is proving to be a powerful force supporting prices.”

The bank went on to criticize media representations of the oil market as “tight,” adding that “[w]e do not think a market with more than a billion barrels of excess inventories and more than 10 million barrels per day (mb/d) of spare capacity in OPEC+ can be described as tight.” While global supply may fall below demand in the coming months, it would take roughly two years to bring inventories back to the five-year average, the bank noted.

Meanwhile, many U.S. shale companies are drowning in debt. Just a few days ago, Extraction Oil & Gas, a large shale driller in Colorado, declared bankruptcy. Chesapeake Energy, which arguably best represents the debt-driven shale bonanza, is expected to file for bankruptcy any day now. The Chapter 11s, and even the “Chapter 22s” – a nickname for those that are set to declare bankruptcy for the second time – are expected to continue to rise.

All the while, steep decline rates will likely more than overwhelm any new drilling that takes place. Oil prices have bounced off of April lows, but U.S. shale is far from a comeback.

By Nick Cunningham of Oilprice.com

https://oilprice.com/Energy/Crude-Oil/When-Wi...evels.html
Scroll down for more posts ▼

Top 10 Most Recent News Articles

OSL Unveils Instant Redemption for USDGO Plus SP

Updated Category News Views 148

OSL's New Move: Instant Redemption on the Table Alright, let's chew over OSL's latest gambit—you know, those folks (HKEX: 863) who are knee-deep in the digital currency swamp. They've launched this "Instant Redemption" feature for these fancy real-world asset products, and USDGO Plus SP is right there at the forefront. Getting the Fine Print Straight Now, not just...

Continue Reading
PG&E, Edison Push Liability Cap Amid Firestorm

Updated Category News Views 152

The Thanksgiving Playbook Nobody Wanted Sacramento's corridors are buzzing with electric tension. And why? It's not some trivial turkey drama but a simmering scandal over two utility giants trying to sneak a liability cap into law faster than you can ask for a second slice of pumpkin pie. PG&E and Edison have a little secret—a covert strategy to limit shareholder...

Continue Reading
Montefiore Einstein Takes On Breast Cancer's Hidden Battle

Updated Category News Views 49

Call me old-fashioned, but when cancer whispers in the shadows even after it's supposedly signed off the death certificate, you're dealing with one heck of a slippery adversary. That's where Montefiore Einstein Comprehensive Cancer Center comes in, armed with ten million greenbacks from the National Cancer Institute, primed to rattle the labyrinth of breast cancer...

Continue Reading
Tulsa Hosts Gradient's Global Tech and Investment Event

Updated Category News Views 89

Tulsa's New Spotlight: Gradient's CHROMA Event Well, look at Tulsa, becoming the center of the tech and enterprise universe for a day. Gradient is throwing open the doors for its second annual CHROMA event on September 24, 2026. You might scratch your head and say, ‘Tulsa? Really?’ But hear me out—this isn’t just a local shindig. We're talking about a one-day...

Continue Reading
Minghui and ASKA Seal Major Licensing Deal for MHB018A

Updated Category News Views 164

Breaking New Ground in Thyroid Eye Disease Treatment If there's one thing that keeps the biopharma world on its toes, it's the relentless pursuit of groundbreaking treatments. And folks, let me tell you, the latest tie-up between Minghui Pharmaceutical and ASKA Pharmaceutical has struck a chord. This union with MHB018A at its core might be one of those watershed moments...

Continue Reading
Cloud Software Group Amends $2B Cash Tender Offer

Updated Category News Views 89

Cloud Software Group is stirring the pot with an amendment that'll have bondholders looking twice at their portfolios. On November 3, 2026, the company announced a tweak to its cash tender offer, bumping up the payment for its 9.00% Senior Secured Second Lien Notes due 2029. The payout now jumps from $1,017.50 to $1,022.50 for each $1,000 of principal. If you're holding...

Continue Reading
Japan's RWE Market Transformation: TXP's Insightful Whitepaper

Updated Category News Views 55

Unraveling the Real-World Evidence Landscape in Japan The folks at TXP Medical just dropped a bombshell of a whitepaper that'll have Medical Affairs departments buzzing. Imagine waking up to a market that's exploding by over 500% in just a decade—yeah, I'm talking about the EMR-derived data market in Japan. These guys are saying it's gonna shoot from ¥3.9 billion in...

Continue Reading
Hyundai Pushes Hydrogen Boundaries at 2026 Expo

Updated Category News Views 105

A Bold Step Into the Hydrogen Era Hyundai's really stepping it up at the World Hydrogen Expo 2026. They're not just dipping their toes in the hydrogen pool—they're diving in headfirst, showing off integrated hydrogen solutions that are nothing short of ambitious. Hydrogen Production That's a Real Game Changer This ain't just talk. Hyundai's showcasing modular PEM...

Continue Reading
Qapture's Institutional Stablecoin Venture Unveiled

Updated Category News Views 69

Stablecoin Strategy Meets Institutional Investment Here's a fresh one from the digital asset universe. We're talking about Qapture Investments' bold move to launch an institutional-grade stablecoin yield strategy. This ain't your average kitchen table crypto chat—it's the Qapture Safe Haven Vault (QHVN-USD), tailored for those looking to get a better return on their...

Continue Reading
Hormel Foods Sets Stage for Q4 Earnings Call in December

Updated Category News Views 124

Hormel Foods Prepares for Earnings Spotlight In a world where market instability feels like the only constant, Hormel Foods Corporation (NYSE:HRL) is setting up one of those must-watch moments. You've got DECEMBER 3rd circled on your cal, right? If not, you're about to miss a curtain raiser that could send ripples across portfolios. Setting the Stage: December's Big...

Continue Reading

Top 5 Most Recently Viewed Articles

KAYALI Unveils Irresistible Oudgasm Fragrances for All

Updated Category News Views 370

KAYALI Introduces Exciting New Fragrances KAYALI, the extraordinary fragrance house created by Mona Kattan, has once again captivated the world by expanding its popular Oudgasm Collection. The new scents include Oudgasm Chocolate Oud | 11 Eau de Parfum Intense and Oudgasm Milky Musk Oud | 30 Eau de Parfum Intense. These additions offer an innovative twist on oud, one of...

Continue Reading
Ingersoll Rand Announces Earnings Release and Call Details

Updated Category News Views 68

Ingersoll Rand Inc. (NYSE: IR) was gearing up to drop its third-quarter earnings in October 2024, and you know how these releases can shake the tree. With the market closing on a Thursday, traders were already calculating their bets ahead of this release—a classic pre-weekend play where anything could happen. What Traders Anticipated from Ingersoll Rand's Q3 Earnings...

Continue Reading
AppWork Secures Significant Funding to Enhance Operations

Updated Category News Views 218

AppWork Secures $13 Million in Series A Funding Investment will accelerate product development and customer success as AppWork scales its industry-leading platform AppWork, a fast-growing software platform designed to optimize maintenance operations for multifamily property management teams, has successfully secured $13 million in Series A funding. The investment was led...

Continue Reading
Mecho's Launch of EcoGlass Blackout Enhances Sustainability Efforts

Updated Category News Views 195

Mecho Enhances Sustainability with EcoGlass Blackout Mecho, a renowned leader in commercial shading solutions, has recently accomplished a significant sustainability milestone by introducing Environmental Product Declarations (EPDs) for its motorized shade systems, alongside its groundbreaking product EcoGlass Blackout. This innovative blackout fabric is the first of its...

Continue Reading
Vivoryon Therapeutics N.V. Prepares for Q1 2025 Financial Update

Updated Category News Views 318

Vivoryon Therapeutics N.V. Announces Q1 2025 Financial Results Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) is gearing up to unveil its financial results for the first quarter of 2025. This announcement is pivotal as it not only reflects the company's financial health but also signals its ongoing commitment to advancing treatments for inflammatory...

Continue Reading